Evidence map›Paper›PMID 37060107›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Structure Transformation and Morphologic Modulation of Supramolecular Frameworks for Nanoseparation and Enzyme Loading.

Mingfeng Wei, Bao Li, Lixin Wu

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mingfeng WeiState Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun, 130012, China.
Bao LiState Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun, 130012, China.ORCID 0000-0003-0727-9764
Lixin WuState Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun, 130012, China.ORCID 0000-0002-4735-8558
Jilin University · CN

Funding

National Natural Science Foundation of China 22172060National Natural Science Foundation of China 22271117Program for JLU Science and Technology Innovative Research Team 2017TD-10
6 · The paper itself

Abstract

Supramolecular framework (SF) encourages the emergence of porous structures with molecular flexibility while the dimension and morphology controls are less involved even though critical factors are vital for various utilizations. Targeting this purpose, two isolated components are designed and their stepped combinations via ionic interaction, metal coordination, and hydrogen bond into framework assembly with two morphologic states are realized. The zinc coordination to an ionic complex of polyoxometalate with three cationic terpyridine ligands constructs 2D hexagonal SF structure. A further growth along perpendicular direction driven by hydrogen bonding between grafted mannose groups leads to 3D SF assemblies, providing a modulation superiority in one framework for multiple utilizations. The large area of multilayered SF sheet affords a filtration membrane for strict separation of nanoparticles/proteins under gently reduced pressures while the granular SF assembly demonstrates an efficient carrier to load and fix horse radish peroxidase with maintained activity for enzymatic catalysis.

Indexed as

MetalsZincMetalsZinc2D/3D interconversionenzyme carriermembrane separationmultiple interactionssupramolecular framework

Identifiers

PMID37060107
PMCPMC10238212
OpenAlexW4365811230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.